Mayo Clinic · 2 hours ago
Research Technologist - Elyaman Lab (2-year Limited Tenure)
Mayo Clinic is a top-ranked healthcare provider dedicated to putting the needs of patients first while also investing in their employees. The Research Technologist role involves performing routine lab procedures, data collection, and analysis to support lab goals and grant commitments under supervision.
BiotechnologyHealth CareHospitalMedicalWellness
Responsibilities
Sets up and performs routine and established lab procedures in support of lab goals, grant commitments, i.e. assays, cell/tissue culture, animal studies, etc
Monitors results, reports unusual outcomes and suggests modifications
Collects, enters and summarizes data
Assists in the maintenance of lab equipment and supplies
Performs basic statistical data analysis; prepares tables/charts/graphs and assists in organizing data
Presents at research laboratory meetings and contributes to writing of manuscripts
Works under supervision and may perform some assignments independently as discussed and approved by Principal Investigator
Qualification
Required
Requires bachelor's degree in biology, chemistry, other relevant science, or an associates degree with 6 years of relevant laboratory experience
Must exhibit a solid understanding of lab techniques, equipment, and safety
Must have the ability to organize and carry out laboratory techniques independently and in a team setting
Experience with basic data analysis is required
This position requires demonstrated writing skills
Preferred
Bioinformatics and Genomics Analysis experience
Degree in Bioinformatics and Computational Biology
Benefits
Medical: Multiple plan options.
Dental: Delta Dental or reimbursement account for flexible coverage.
Vision: Affordable plan with national network.
Pre-Tax Savings: HSA and FSAs for eligible expenses.
Retirement: Competitive retirement package to secure your future.
Company
Mayo Clinic
MayoClinic is a nonprofit medical practice and medical research group focused on integrated health care, education, and research.
Funding
Current Stage
Late StageTotal Funding
$399.05MKey Investors
The ALS AssociationNational Institute of Neurological Disorders and StrokeAmerican Heart Association
2025-12-04Grant· $0.95M
2024-09-24Grant· $12M
2023-07-26Grant
Recent News
2026-01-25
2026-01-23
Medical Xpress - latest medical and health news stories
2026-01-23
Company data provided by crunchbase